Survival in Patients with Glioblastoma Receiving Valganciclovir
Cited by 189Open Access
Abstract
A retrospective analysis of selected patients with glioblastoma who received treatment for cytomegalovirus with their anticancer treatment showed surprisingly good 2-year survival. A randomized trial is needed.
Related Papers
No related papers found
Powered by citation graph analysis